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Preterm Labor Update 
 
Preterm birth is the leading cause of neonatal mortality in the United States, and preterm 
labor precedes approximately 40-50-% of preterm births.  In the United States 12.1% of all 
births are preterm, in Iowa that percentage is 11.6%.   These births account for 75% of 
neonatal mortality and 50% of long-term neurologic impairments in children.  Despite 
numerous management methods used in the last 40 years, the incidence of preterm birth 
has not changed.  The following is a summary of ACOG’s Practice Bulletin on 
“Management of Preterm Labor” published in May 2003 (#43).  
 
Background Information 
 
The definition of preterm labor is regular contractions that occur before 37 weeks of 
gestation and are associated with cervical change.  Most women with presumptive preterm 
labor will not have preterm delivery.  It is important to remember that many preterm births 
are preceded by rupture of membranes or other medical problems,  these issues will not be 
discussed at this time.  Historically, many interventions have been used without any 
evidence to support their use.  These include bed rest, abstention from intercourse and 
orgasm, and hydration.  This ACOG publication does not recommend their continued use. 
 
Antibiotic Treatment   
 
Antibiotic treatment has been utilized based on the theory that infections or inflammation is 
associated with contractions.  Studies have shown mixed results and fail to show benefit.  
Treating women in preterm labor with antibiotics for the sole purpose of preventing preterm 
delivery is not recommended.  It is suggested that protocols for antibiotic prophylaxis 
against early-onset group B streptococcal sepsis be followed as outlined by the CDC. 
 
Antenatal Corticosteroids 
 
Betamethasone or Dexamethasone significantly reduces the incidence and severity of 
neonatal respiratory distress syndrome.  Its’ use also shows a decrease in intraventricular 
hemorrhage and necrotizing entercolitis, as well as neonatal mortality.  All women who are 
at risk for preterm delivery between 24 and 34 weeks are potential candidates for 
administration of one of these steroids.  Only one course is recommended during the 
pregnancy. 
 
Tocolytic Medications 
 
Many agents have been used and studies are conflicting regarding their effectiveness.  All 
have demonstrated only limited benefit.  There is no clear first-line tocolytic drug.  The 
prolonged use of any tocolytic drug may potentially increase the maternal-fetal risk without 
offering a clear benefit.  Combining tocolytic drugs potentially increases maternal morbidity 
and should be used with caution.  Recently the University of Iowa Hospital Department of 
Obstetrics decided to use Nifedipine (Procardia) as their primary tocolytic based on the 
recommendation of the Cochrane database.  Oral administration of Nifedipine reaches 
maximum plasma levels in 20-30 minutes and the half-life is 1-11/2 hours.  Nifedipine 
causes vasodilation and decreased vascular resistance.  The most common maternal side 
effects include facial flushing, headache, and nausea, others are palpitations, transient 
tachycardia, and lightheadedness.  It is contraindicated in liver disease, hypotension, 
congestive heart failure, and aortic stenosis.  No neonatal side effects have been reported.  
Suggested schedule of administration is 10 mg orally every 20-30 minutes for up to 40 mg 
in an hour, then 10-20 mg every 4-6 hours.  Monitor blood pressure and pulse, FHR, and 
uterine activity every 15 minutes x 2 following initial dose and prior to each subsequent 
dose.  Hold the medication if BP<100/60 and pulse>120 and notify the physician. 
 
Questions and Answers    
 
Should treatment be repeated?  The benefits are uncertain. 
Should an amniocentesis be performed?  Could be useful if maturity is a possibility or to 
establish intraamniotic infection, but results might not be available quickly enough to affect 
decision- making. 
Should multiple gestations be any different than singletons in treating?  No, but remember 
these women are at greater risk for pulmonary edema when given beta-mimetics or 
magnesium sulfate. 
Is there a benefit of tocolytics for the neonate?  Yes, because time allows the 
administration of steroids or the mother to be transported to a tertiary hospital for 
resuscitation of the baby. 
What about fetal fibronectin and vaginal ultrasound?  Their benefit is in the ability to predict 
women who are least likely to deliver, therefore, avoiding unnecessary intervention. 
Anything new in this area?  In selected high- risk population for preterm labor, progesterone 
suppositories or injections may be beneficial. 
 
 
 
FOR QUESTIONS OR COMMENTS:  Contact Kathy Papke, R.N. or Penny Smith, R.N.C, 
Statewide Perinatal Care Program, Department of Pediatrics, 200 Hawkins Dr., Iowa City, Iowa 
52242-1083  Call (319) 356-2637 or FAX 319-353-8861. 
 
 
